SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. – PLX
NEW YORK, June 3, 2021 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Protalix BioTherapeutics, Inc. (“Protalix” or the “Company”) (NYSE: PLX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
The investigation concerns whether Protalix and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class…
